Diseases, Conditions, Syndromes

Positive results for Lilly and Regeneron COVID antibodies

US pharmaceutical company Eli Lilly's combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in high-risk patients with recent positive tests, the company said Tuesday.

Oncology & Cancer

Reviving exhausted immune cells to fight cancer

Eliminating a single gene can turn exhausted cancer-fighting immune cells known as CD8+ T cells back into refreshed soldiers that can continue to battle malignant tumors, a new study led by UT Southwestern researchers suggests. ...

page 1 from 3